PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 260 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,836,000 | -22.9% | 31,495 | +0.9% | 0.18% | -14.1% |
| Q1 2022 | $2,382,000 | +98.7% | 31,205 | +56.6% | 0.21% | +110.2% |
| Q4 2021 | $1,199,000 | +3.6% | 19,929 | -3.5% | 0.10% | -3.0% |
| Q3 2021 | $1,157,000 | -10.0% | 20,657 | -2.6% | 0.10% | -5.6% |
| Q2 2021 | $1,286,000 | -12.6% | 21,201 | +0.9% | 0.11% | -17.7% |
| Q1 2021 | $1,472,000 | +11.0% | 21,005 | -5.2% | 0.13% | +6.6% |
| Q4 2020 | $1,326,000 | -1.0% | 22,166 | -0.5% | 0.12% | -1.6% |
| Q3 2020 | $1,339,000 | – | 22,277 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
| Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
| Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
| Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
| ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
| RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
| Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
| OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
| Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |